India, April 30 -- Nutriband Inc. (NTRB) rose 21.21 percent to $6.89, gaining $1.21 during Wednesday's trading, after CEO Gareth Sheridan published a shareholder letter outlining 2024 milestones and the outlook for 2025.
The stock opened at $7.10 and traded between $6.45 and $8.11 on volume of 422,842 shares, significantly above the average of 65,813. Nutriband's 52-week range spans from $3.30 to $11.78.
The update emphasized progress toward commercialization of the company's AVERSA abuse deterrent transdermal technology, which targets drugs like fentanyl and buprenorphine.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....